Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-04-05 @ 6:05 AM
Study NCT ID:
NCT00468169
Status:
COMPLETED
Last Update Posted:
2019-10-09
First Post:
2007-04-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer
Sponsor:
University of Chicago
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Cancer | View |